Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3231 results

Sort By:

Screen Addiction and Postoperative Pain

Study ID: NCT07242872
Start Date: 2026-01-01
End Date: 2026-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Tokat Gaziosmanpasa University

Source: clinicaltrials.gov

Share:
Add to list

Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia

Study ID: NCT06910423
Start Date: 2026-01-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment

Psychosocial intervention

Sponsor

College of Professional and Continuing Education Limited

Source: clinicaltrials.gov

Share:
Add to list

Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 2% Mepivacaine in Patients Undergoing Outpatient Primary Total Knee Arthroplasty

Study ID: NCT07239999
Start Date: 2026-01-12
End Date: 2027-01-15
Study Type

Interventional

Study Phase

Phase4

No. of Participants

80

Intervention / Treatment

Mepivacaine Injection

Chloroprocaine Injection

Sponsor

Nova Scotia Health Authority

Source: clinicaltrials.gov

Share:
Add to list

An Intervention to Reduce Discrepancy in Everyday Preferences

Study ID: NCT03577418
Start Date: 2026-04
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Templated, clinician-facilitated intervention to align everyday living preferences assessment

Sponsor

Mclean Hospital

Source: clinicaltrials.gov

Share:
Add to list

Improving Preterm Kidney Outcomes With Caffeine

Study ID: NCT07262060
Start Date: 2026-03
End Date: 2030-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

Caffeine citrate

Placebo

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Do Emotions and Pain Combined Affect Mechanical Pain Thresholds and Other Pain-related Variables in Individuals with Chronic Pain?

Study ID: NCT06851208
Start Date: 2026-03-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Emotional intervention

Emotional intervention

Emotional intervention

Sponsor

Linnaeus University

Source: clinicaltrials.gov

Share:
Add to list

Vagal Stimulation Therapy and Preeclampsia

Study ID: NCT06953115
Start Date: 2026-02-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

210

Intervention / Treatment

Vagal stimulation physiotherapy with trigger point release

Positional Release Therapy

Sponsor

René Mey International Foundation

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Study ID: NCT07266818
Start Date: 2025-12-17
End Date: 2026-03-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

MK-1167

Placebo

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC

Study ID: NCT07245797
Start Date: 2025-12-15
End Date: 2027-02-23
Study Type

Interventional

Study Phase

Phase2

No. of Participants

164

Intervention / Treatment

fixed-dose combination of pertuzumab and trastuzumab as subcutaneousformulation q3w and nab-paclitaxel in 3-week cycle for total 6 cycles with inavolisib (6 cycles) or without inavolisib.

Sponsor

Z him INS good

Source: clinicaltrials.gov

Share:
Add to list

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Study ID: NCT07047690
Start Date: 2025-12-15
End Date: 2027-10-29
Study Type

Interventional

Study Phase

Phase2

No. of Participants

162

Intervention / Treatment

Nemolizumab

Placebo

Sponsor

Galderma R&D

Source: clinicaltrials.gov

Share:
Add to list